Key result
The modular cardiac rhythm management system evaluated in the MODULAR ATP trial offers a personalized device medicine approach for addressing sudden cardiac arrest.
Clinical trial demonstrates modular antitachycardia pacing performance in sudden cardiac arrest prevention, highlighting opportunities for personalized device therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zaman et al. (2024) studied this question. The modular cardiac rhythm management system evaluated in the MODULAR ATP trial offers a personalized device medicine approach for addressing sudden cardiac arrest.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: